Rh immunoglobulin prophylaxis is a preventive treatment given to Rh-negative individuals to prevent the formation of antibodies against Rh-positive blood cells, which can lead to hemolytic disease of the fetus and newborn in subsequent pregnancies. It is typically administered during pregnancy and after delivery if the newborn is Rh-positive, as well as after any event where fetal blood cells might enter the maternal circulation.